Evans Terry L — SEC Form 4 filings
SEC reporting owner CIK 2043317. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-31.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-11-13 to 2026-08-31. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| FENNEC PHARMACEUTICALS INC. (FENC) | Chief Commercial Officer | 9 | — | — | 12 |
Form 4 filings — Evans Terry L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-31 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 168 @ $0 | EDGAR |
| 2026-08-03 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 168 @ $0 | EDGAR |
| 2026-07-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 168 @ $0 | EDGAR |
| 2026-06-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 168 @ $0 | EDGAR |
| 2026-05-01 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 168 @ $0 | EDGAR |
| 2026-04-02 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 18,456 @ $0 · Option exercise (M): 171 @ $0 · Option exercise (M): 2,052 @ $0 · Grant/award (A): 120,000 (derivative) @ $5.77 | EDGAR |
| 2025-04-03 | 4/A | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-11-13 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 150,000 (derivative) @ $4.23 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2043317 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →